Allogene Therapeutics, Inc.

TPG GP A, LLC ALLO
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/15/2026
Shares
18,716,306
Value ($000)
45,668
Weight
1.2%
2025 Q2 - 2026 Q1 (4 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).